Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioRestorative Therapies (BRTX)
NASDAQ:BRTX
RESEARCH TOOLSreports
BioRestorative Therapies (BRTX) Stock Price & Analysis
128 Followers
BRTX Stock Chart & Stats
Day’s Range$1.21 - $1.27
52-Week Range― - ―
Previous Close$1.27
Volume48.83K
Average Volume (3M)N/A
Market Cap
$9.00M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 15, 2018EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$15.00Price Target Upside1090.48% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
BioRestorative Therapies News
Options Prices
Currently, No data available
---
Ownership Overview
37.63% Insiders
2.40% Mutual Funds
0.89% Other Institutional Investors
59.08% Public Companies and
Individual Investors
BRTX FAQ
What was BioRestorative Therapies’s price range in the past 12 months?
Currently, no data Available
What is BioRestorative Therapies’s market cap?
Currently, no data Available
When is BioRestorative Therapies’s upcoming earnings report date?
BioRestorative Therapies’s upcoming earnings report date is May 15, 2018 which is 2172 days ago.
How were BioRestorative Therapies’s earnings last quarter?
Currently, no data Available
Is BioRestorative Therapies overvalued?
According to Wall Street analysts BioRestorative Therapies’s price is currently Undervalued.
Does BioRestorative Therapies pay dividends?
BioRestorative Therapies does not currently pay dividends.
What is BioRestorative Therapies’s EPS estimate?
BioRestorative Therapies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioRestorative Therapies have?
Currently, no data Available
What happened to BioRestorative Therapies’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of BioRestorative Therapies?
Currently, no hedge funds are holding shares in BRTX
---
BioRestorative Therapies Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$15.00 (1090.48% Upside)
$15.00 (1090.48% Upside)
Insider Transactions
Bought Shares
Worth $378.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 6.3%
Last 30 Days ▼ 9.2%
Last 30 Days ▼ 9.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-67.92%
12-Months-Change
Fundamentals
Return on Equity
-105.30%
Trailing 12-Months
Asset Growth
-23.26%
Trailing 12-Months
Company Description
BioRestorative Therapies
Biorestorative Therapies Inc. provides stem cell collections, storage, and treatment services. It intends to develop a laboratory, performing cellular characterization and culturing, therapeutic outcomes analysis, stem cell-related IP and stem cell collection and storage services. The company is developing the following scientific initiatives: brtxDISC Program offers a non-surgical treatment for bulging and herniated discs and addresses the gap between non-invasive and invasive back procedures. The ThermoStem Program focuses on treatments for metabolic disorders and obesity and uses brown fat stem cells, which initial research indicates increased caloric burning and reduced glucose and lipid levels in the body. It also offers plant stem cell-based facial creams and products under the Stem Pearls brand. Biorestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.
---
BRTX Stock 12 Months Forecast
Average Price Target
$15.00
▲(1090.48% Upside)
Technical Analysis
Best Analysts Covering BRTX
1 Year
1 Year Success Rate
0/7 ratings generated profit
1 Year Average Return
-54.71%
reiterated a buy rating 10 days ago
Copying Michael Okunewitch's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -54.71% per trade.
---